Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading on policies involving artificial ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial intelligence and software as a medical device.

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

Pro-choice advocates say the science is settled on the abortion pill mifepristone, but critics argue that better safeguards ...

Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...

Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...

The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...

Overcoming data sharing and collaboration silos to achieve the visibility needed to comply with new regulations means opportunities to improve food safety.

The 10% tariffs on Chinese goods began Tuesday. China reacted with a 15% tariff on coal and liquefied natural gas and a 10% tariff on crude oil, agricultural machinery, large-displacement automobiles ...

A son of a Democratic political dynasty, Kennedy is seeking to become the nation's top health official under President Donald ...

One year after being acquired by Global Alzheimer’s Platform Innovations, Tampa-based Axiom Brain Health has expanded its ...